Patients should "Ask-In"
on clinical trials participation
African American participation in prostate cancer clinical trials must move from the 3-5% range to the 10-12% level in order to determine the effectiveness of new treatments for this population with the highest prostate cancer incidence and death rates.
As part of its
Clinical Trials Rally
PHEN is encouraging all Prostate cancer patients to
on clinical trials participation by searching out specific trials as treatment options to discuss with their doctors.
There can be immediate benefits for patients who participate in prostate cancer clinical trials including access to treatments and expert care that may not otherwise be available or affordable.
PHEN is comfortable recommending that black men embrace clinical trial participation because today there are regulations and review boards governing the medical institutions participating in clinical trials that insure patient safety.
More than 80% of attendees at PHEN's clinical trials educational programs indicate that they are willing to consider participating in trials after they have understood the benefits and risks
"Ask - In" and you may find that your best treatment
option is a clinical trial.